Open AccessSecondary Infections in Hospitalized COVID-19 Patients: Indian Experience
Author(s) -
Sonam Vijay,
N.K. Bansal,
B. K. Rao,
Balaji Veeraraghavan,
Camilla Rodrigues,
Chand Wattal,
Jagdish Prasad Goyal,
Tadepalli Karuna,
Purva Mathur,
Venkateswaran Ramesh,
V Ramasubramanian,
Sagar Khadanga,
Sanjay Bhattacharya,
Sudipta Kumer Mukherjee,
Sujata Baveja,
Sarath Chandra Sistla,
Samiran Panda,
Kāmini Walia
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s299774
Subject(s) - covid-19 , medicine , virology , pandemic , outbreak , infectious disease (medical specialty) , disease
Critically ill coronavirus disease 2019 (COVID-19) patients need hospitalization which increases their risk of acquiring secondary bacterial and fungal infections. The practice of empiric antimicrobial prescription, due to limited diagnostic capabilities of many hospitals, has the potential to escalate an already worrisome antimicrobial resistance (AMR) situation in India. This study reports the prevalence and profiles of secondary infections (SIs) and clinical outcomes in hospitalized COVID-19 patients in India.